middle.news
AlgoraeOS v2 Outperforms Google DeepMind in AI Drug Discovery Upgrade
9:05am on Monday 10th of November, 2025 AEDT
•
Healthcare
Read Story
AlgoraeOS v2 Outperforms Google DeepMind in AI Drug Discovery Upgrade
9:05am on Monday 10th of November, 2025 AEDT
Key Points
AlgoraeOS v2 outperforms Google DeepMind’s TxGemma-27B-Predict and Tx-LLM (M)
Trained on over 5.5 million unique inhibition records with multi-metric dose-response modeling
Confidence-weighted predictions enable risk-aware experimental design
Integration planned across Algorae’s preclinical pipeline with fixed-dose combination predictions due Q4 2025
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Algorae Pharmaceuticals (ASX:1AI)
OPEN ARTICLE